Press Releases
West Palm Beach State Representative Receives National Award for Alzheimer’s Volunteerism
The Global Alzheimer’s Platform Foundation® Recognizes Rep. Matt Willhite (D-86) with the 2020 National Citizen Scientist Collaborator Award® Contact: Pamela Larkin – [email protected], 408-466-5952 Contact: Belinda Russel – [email protected], 561-968-2933 West Palm Beach, FL (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) has recognized State Representative Matt Willhite (D-86) as the honoree of […]
Pawleys Island Resident with Alzheimer’s Receives National Award for Alzheimer’s Volunteerism
The Global Alzheimer’s Platform Foundation® Recognizes Deborah Whelan with the 2020 National Citizen Scientist Champion Award® Contact: Pamela Larkin – [email protected], 408-466-5952 Contact: Robert Briggs – [email protected], 267-879-1762 Charleston, SC (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) has recognized Deborah Whelan, a retiree living with Alzheimer’s disease, as the recipient of the National Citizen Scientist Champion Award®. […]
Westford Retiree Receives National Award for Alzheimer’s Volunteerism
The Global Alzheimer’s Platform Foundation® Has Recognized Dennis Chan for the 2020 National Citizen Scientist Catalyst Award® Contact: Pamela Larkin – [email protected], 408-466-5952 Boston, MA (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) has recognized Westford retiree Dennis Chan as the honoree of the National Citizen Scientist Catalyst Award®. The Center for Alzheimer […]
St. Louis Psychiatrist and Diversity Advocate Receives National Award for Volunteerism with Knight Alzheimer’s Disease Research Center
The Global Alzheimer’s Platform Foundation® Has Recognized Dr. Collins Lewis for the 2020 National Citizen Scientist Cornerstone Award® Contact: Pamela Larkin – [email protected], 408-466-5952 St. Louis, MO (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) has recognized St. Louis psychiatrist Dr. Collins Lewis as the honoree of the National Citizen Scientist Cornerstone Award®. […]
FOUR ALZHEIMER’S CLINICAL TRIAL VOLUNTEERS HONORED WITH NATIONAL CITIZEN SCIENTIST AWARDS® FOR THEIR DEDICATED WORK IN THE SEARCH FOR A CURE
Global Alzheimer’s Platform Foundation® National Honorees Include an Advocate with Alzheimer’s Disease, a Doctor with a Family History of Alzheimer’s, a Caregiver and Legislator, and a Retiree in a Clinical Trial Washington, DC (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) is honoring four Alzheimer’s disease clinical trial volunteers with the 2020 National […]
USC Schaeffer Center Report Insightfully Diagnoses Barriers Facing Alzheimer’s Clinical Trials
GAP’s statement: Study cites limited awareness among patients and physicians, anxiety, and lack of quick diagnostics Washington, DC (August 20, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding a University of Southern California Louis D. Schaeffer Center for Health Policy & Economics white paper, “Key Barriers to […]
Global Alzheimer’s Platform Foundation Issues Statement on Recent Groundbreaking Advances in Alzheimer’s Blood Tests
Washington D.C. (July 30, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding recent groundbreaking advances in Alzheimer’s blood test research: “I want to congratulate and thank Dr. Barthélemy, Dr. Horie, Dr. Sato, Dr. Bateman, Dr. Palmqvist, Dr. Janelidze, and Dr. Quiroz on their published research on two […]
Global Alzheimer’s Platform Foundation Statement on Biogen’s Submission of Aducanumab Application to the FDA
Washington D.C. (July 9, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding Biogen’s submission of its BLA application for Aducanumab with the FDA: “The Alzheimer’s research community is looking forward to a thoughtful review of Aducanumab and ideally, approval by the FDA. This application represents a singular […]
GAP Statement on Racial Inequality
June 2, 2020 The events that spurred the reaction around the country this weekend are painful reminders that injustice remains in our world. At the Global Alzheimer’s Platform Foundation® (GAP), we agree that monumental changes on local and national levels are necessary to address the issues plaguing Black and African American people in our country […]
Investors Meet Opportunity at Inaugural Global Alzheimer’s Platform Foundation Innovation Summit
At a pivotal time in Alzheimer’s research, the GAP Foundation and the Alzheimer’s Drug Discovery Foundation will connect funders with leading innovators Updated on March 26, 2020: The Global Alzheimer’s Platform Foundation (GAP) has announced it is postponing the GAP Innovation Summit that was to be held on May 5, 2020 with our partner, the […]